Takeda pays $60M upfront with $600M in milestones
预付约6000万美元，其余6亿美元与里程碑付款和销售分成挂钩。
English original
roughly sixty million upfront with the remaining six hundred million tied to milestones and royalties
在CNBC关于武田交易的采访中
A
亚历克斯·扎沃龙科夫Insilico Medicine · 创始人
报道摘要
Alex Zhavoronkov, Founder, CEO & CBO of Insilico Medicine, says the Takeda deal lets the company scale beyond its own pipeline and become a top global player in AI drug discovery. He breaks down the ...
CNBC